XOMA Announces Pricing of Approximately $50.0 Million Offering of Common Stock Dec 13, 2013 9:13am EST
XOMA Highlights Recent Achievements and Reports Financial Results for Third Quarter 2013 Nov 07, 2013 4:01pm EST
XOMA to Announce Third Quarter 2013 Financial Results and Host Webcast on November 7 Oct 31, 2013 5:00pm EDT
Results From Two Phase 2 Studies in XOMA's Gevokizumab Proof-of-Concept Program Are Very Encouraging and Compelling Oct 30, 2013 4:42pm EDT
XOMA Announces Closing of the Offering and Exercise of Over-Allotment Option Aug 23, 2013 12:12pm EDT
